A systematic review of landmark CD44‐related studies could facilitate a better understanding of the functional role of CD44 in cancer development and progression and thus will contribute to the development of novel strategies to circumvent their disadvantage and acquire optimal clinical efficacy. This evidence concerns the gene CD44 and cancer.